DOI QR코드

DOI QR Code

Epithelioid sarcoma associated with neurofibromatosis type I

  • Hwang, Sung Oh (Department of Plastic and Reconstructive Surgery, Inje University Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Lee, Soo Hyang (Department of Plastic and Reconstructive Surgery, Inje University Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Lee, Han Byul (Department of Plastic and Reconstructive Surgery, Inje University Ilsan Paik Hospital, Inje University College of Medicine)
  • Received : 2019.11.04
  • Accepted : 2019.12.16
  • Published : 2020.02.20

Abstract

In general, patients with neurofibromatosis type I have a higher risk than those with other types of neurofibromatosis of developing soft-tissue sarcomas related to the nervous system. We here present a 42-year-old man with neurofibromatosis type I who developed a protruding mass over only 2 weeks. The histopathological diagnosis was epithelioid sarcoma. Epithelioid sarcomas are rare and, to the best of our knowledge, no epithelioid sarcomas have been reported in patients with neurofibromatosis type I. Radical excision of the primary lesion was performed and postoperative radiotherapy and chemotherapy administered, as is recommended for epithelioid sarcoma. Our case emphasizes that patients with neurofibromatosis type I may develop malignant tumors.

Keywords

References

  1. Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol 2005;32:221-8. https://doi.org/10.1016/j.pediatrneurol.2004.11.002
  2. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms. N Engl J Med 1986;314:1010-5. https://doi.org/10.1056/NEJM198604173141603
  3. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-4. https://doi.org/10.1136/jmg.39.5.311
  4. de Oliveira MG, Pozatti Moure S, Sergio Batista P, Moraes Chaves AC, Rados PV, Sant'Ana Filho M. NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report. Oral Maxillofac Surg 2008;12:231-5. https://doi.org/10.1007/s10006-008-0137-1
  5. Ferrari A, Bisogno G, Macaluso A, Casanova M, D'Angelo P, Pierani P, et al. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer 2007;109:1406-12. https://doi.org/10.1002/cncr.22533
  6. Kim A, Stewart DR, Reilly KM, Viskochil D, Miettinen MM, Widemann BC. Malignant peripheral nerve sheath tumors state of the science: leveraging clinical and biological insights into effective therapies. Sarcoma 2017;2017:7429697.
  7. Chowdhry M, Hughes C, Grimer RJ, Sumathi V, Wilson S, Jeys L. Bone sarcomas arising in patients with neurofibromatosis type 1. J Bone Joint Surg Br 2009;91:1223-6. https://doi.org/10.2106/JBJS.H.00813
  8. Stumpf DA. Neurofibromatosis. Conference statement: National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45:575-8. https://doi.org/10.1001/archneur.1988.00520290115023
  9. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44:81-8. https://doi.org/10.1136/jmg.2006.045906
  10. Friedman JM. Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 2002;17:548-54. https://doi.org/10.1177/088307380201700802
  11. Hatori M, Hosaka M, Watanabe M, Moriya T, Sasano H, Kokubun S. Osteosarcoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Tohoku J Exp Med 2006;208:343-8. https://doi.org/10.1620/tjem.208.343
  12. Shearer P, Parham D, Kovnar E, Kun L, Rao B, Lobe T, et al. Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 1994;22:78-83. https://doi.org/10.1002/mpo.2950220203
  13. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 1984;91:929-35. https://doi.org/10.1016/s0161-6420(84)34217-8
  14. Razek AAKA. MR imaging of neoplastic and non-neoplastic lesions of the brain and spine in neurofibromatosis type I. Neurol Sci 2018;39:821-7. https://doi.org/10.1007/s10072-018-3284-7
  15. Laskowski J. Sarcoma aponeuroticum. Nowotory 1961;11:61-7.
  16. Enzinger FM. Epitheloid sarcoma: a sarcoma simulating a granuloma or a carcinoma. Cancer 1970;26:1029-41. https://doi.org/10.1002/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO;2-R
  17. Spillane AJ, Thomas JM, Fisher C. Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma. Ann Surg Oncol 2000;7:218-25. https://doi.org/10.1007/BF02523657
  18. Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, et al. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:384-91.
  19. Prat J, Woodruff JM, Marcove RC. Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis. Cancer 1978;41:1472-87. https://doi.org/10.1002/1097-0142(197804)41:4<1472::AID-CNCR2820410436>3.0.CO;2-W
  20. Ross HM, Lewis JJ, Woodruff JM, Brennan MF. Epithelioid sarcoma: clinical behavior and prognostic factors of survival. Ann Surg Oncol 1997;4:491-5. https://doi.org/10.1007/BF02303673